Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
FEBS Letters|February 5, 2004
Long-lasting RNAi activity in mammalian neuronsKazuya Omi, Katsushi Tokunaga, Hirohiko HohjohBiochemical and Biophysical Research Communications|November 1, 2005
siRNA-mediated inhibition of endogenous Huntington disease gene expression induces an aberrant configuration of the ER network in vitroKazuya Omi, Naomi S Hachiya, Katsushi Tokunaga, et al.Cancer Science|April 10, 2013
Cisplatin influences acquisition of resistance to molecular-targeted agents through epithelial-mesenchymal transition-like changesMaki Kurokawa, Nobuyuki Ise, Kazuya Omi, et al.Anticancer Research|December 27, 2011
Overexpressed HER2 in NSCLC is a possible therapeutic target of EGFR inhibitorsNobuyuki Ise, Kazuya Omi, Daisuke Nambara, et al.Neuroscience Letters|December 15, 2007
14-3-3zeta is indispensable for aggregate formation of polyglutamine-expanded huntingtin proteinKazuya Omi, Naomi S Hachiya, Mayumi Tanaka, et al.Plos One|September 26, 2024
Continuous quality improvement with a two-step strategy effective for mass SARS-CoV-2 screening at the Tokyo 2020 Olympic and Paralympic GamesHayato Miyachi, Satomi Asai, Rika Kuroki, et al.Biochemical and Biophysical Research Communications|March 16, 2010
Novel monoclonal antibodies recognizing the active conformation of epidermal growth factor receptorNobuyuki Ise, Kazuya Omi, Kyoko Miwa, et al.The Southeast Asian Journal of Tropical Medicine and Public Health|September 16, 2003
Polymorphisms of CD36 in Thai malaria patientsKazuya Omi, Jun Ohashi, Izumi Naka, et al.Parasitology International|November 8, 2002
Fcgamma receptor IIA and IIIB polymorphisms are associated with susceptibility to cerebral malariaKazuya Omi, Jun Ohashi, Jintana Patarapotikul, et al.American Journal of Human Genetics|December 31, 2002
CD36 polymorphism is associated with protection from cerebral malariaKazuya Omi, Jun Ohashi, Jintana Patarapotikul, et al.Pageof 2